Vaxart, Inc.

NasdaqCM:VXRT Stock Report

Mkt Cap: US$145.7m

Vaxart Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure

CEO

Andy Floroiu (49 yo)

2.75yrs

Tenure

US$2,410,175

Compensation

Mr. Cezar Andrei Floroiu, also known as Andy, M.B.A., serves as the Chief Executive Officer at Vaxart, Inc. since June 14, 2020 and served as Principal Financial Officer at Vaxart, Inc. since June 14, 2020...

CEO Compensation Analysis

How has Andy Floroiu's remuneration changed compared to Vaxart's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$105m

Jun 30 2022n/an/a

-US$93m

Mar 31 2022n/an/a

-US$80m

Dec 31 2021US$2mUS$467k

-US$70m

Sep 30 2021n/an/a

-US$64m

Jun 30 2021n/an/a

-US$54m

Mar 31 2021n/an/a

-US$47m

Dec 31 2020US$3mUS$220k

-US$32m

Compensation vs Market: Andy's total compensation ($USD2.41M) is above average for companies of similar size in the US market ($USD727.78K).

Compensation vs Earnings: Andy's compensation has been consistent with company performance over the past year.

Leadership Team

NamePositionTenureCompensationOwnership
Cezar Floroiu
CEO, President & Director2.58yrsUS$2.41mno data
Sean Tucker
Senior VP & Chief Scientific Officer12.92yrsUS$1.19mno data
James Cummings
Chief Medical Officer1.33yrsUS$2.38mno data
Phillip Eric Lee
Chief Financial Officer0.083yrno datano data
Fuad Ahmad
Principal Financial & Accounting Officer0.67yrno data0.0038%
$ 5.6k
Raymond Stapleton
Chief Technology Officer0.42yrno datano data
Edward Berg
Senior VP & General Counsel0.92yrno datano data
Shaily Garg
Senior Vice President of Clinical Development & Project Management2.83yrsno datano data
Brant Biehn
Senior Vice President of Business Operations4.75yrsno datano data
Rajesh Kapoor
Senior Vice President of Quality2yrsno datano data

1.7yrs

Average Tenure

52yo

Average Age

Experienced Management: VXRT's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Cezar Floroiu
CEO, President & Director2.75yrsUS$2.41mno data
Robert Yedid
Lead Independent Director3.25yrsUS$158.00k0.0040%
$ 5.8k
Harry Greenberg
Member of Scientific & Clinical Advisory Board1.42yrsno datano data
Todd Davis
Independent Chairman of the Board3.25yrsUS$171.00k0.090%
$ 131.6k
Michael Finney
Independent Director16yrsUS$152.40k0.50%
$ 728.3k
Stefan Gravenstein
Member of Scientific & Clinical Advisory Board1.42yrsno datano data
David Wheadon
Independent Director1.75yrsUS$485.94k0%
$ 0
Robert Belshe
Member of Scientific & Clinical Advisory Board1.42yrsno datano data
William Watson
Director0.42yrno data0.015%
$ 22.2k
Marion Pepper
Member of Scientific & Clinical Advisory Board1.42yrsno datano data
Ralph Baric
Member of Scientific & Clinical Advisory Board1.42yrsno datano data
Gregory Gray
Member of Scientific & Clinical Advisory Board1.42yrsno datano data

1.4yrs

Average Tenure

63yo

Average Age

Experienced Board: VXRT's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.